Frontlight ResearchEarly access
Trial site
Organización Médica de Investigación
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease2 trials
- Diabetic eye disease2 trials
- Lupus (SLE)2 trials
- Chronic kidney disease1 trial
- Graves' disease1 trial
- Macular degeneration1 trial
- Metastatic breast cancer1 trial
- Obesity1 trial
- Osteoarthritis1 trial
- Schizophrenia1 trial
- Stroke1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 311 trials
- Phase 23 trials
- Status
- Active, not recruiting5 trials
- Recruiting5 trials
- Completed3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche6 trials
- Eli Lilly and Company3 trials
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
- Amgen1 trial
- Biogen1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Chronic kidney disease1 recruiting
- Metastatic breast cancer1 recruiting
- Obesity1 recruiting
- Osteoarthritis1 recruiting
- Schizophrenia1 recruiting
- Stroke1 recruiting
Closed trials
Completed
A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026